Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac
NCT07457307
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
High-grade Glioma
Interventions
DEVICE:
MR-Linac System
RADIATION:
Radiation Therapy
DRUG:
Temozolomide
Sponsor
NYU Langone Health